Digital Therapeutics for Smoking Cessation Market Report – Research, Industry Analysis Reports and Market Demands

Global Digital Therapeutics for Smoking Cessation Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global Digital Therapeutics for Smoking Cessation Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Digital Therapeutics for Smoking Cessation by Company Revenue
- 3.2.2 Top 3 Digital Therapeutics for Smoking Cessation Players Market Share in 2025
- 3.2.3 Top 6 Digital Therapeutics for Smoking Cessation Players Market Share in 2025
3.3 Digital Therapeutics for Smoking Cessation Market: Overall Company Footprint Analysis
- 3.3.1 Digital Therapeutics for Smoking Cessation Market: Region Footprint
- 3.3.2 Digital Therapeutics for Smoking Cessation Market: Company Product Type Footprint
- 3.3.3 Digital Therapeutics for Smoking Cessation Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Digital Therapeutics for Smoking Cessation Consumption Value and Market Share by Type (2021-2026)
4.2 Global Digital Therapeutics for Smoking Cessation Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Application (2021-2026)
5.2 Global Digital Therapeutics for Smoking Cessation Market Forecast by Application (2027-2032)

6 North America

6.1 North America Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2032)
6.2 North America Digital Therapeutics for Smoking Cessation Market Size by Application (2021-2032)
6.3 North America Digital Therapeutics for Smoking Cessation Market Size by Country
- 6.3.1 North America Digital Therapeutics for Smoking Cessation Consumption Value by Country (2021-2032)
- 6.3.2 United States Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 6.3.3 Canada Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2032)
7.2 Europe Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2032)
7.3 Europe Digital Therapeutics for Smoking Cessation Market Size by Country
- 7.3.1 Europe Digital Therapeutics for Smoking Cessation Consumption Value by Country (2021-2032)
- 7.3.2 Germany Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 7.3.3 France Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 7.3.5 Russia Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 7.3.6 Italy Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Digital Therapeutics for Smoking Cessation Market Size by Region
- 8.3.1 Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value by Region (2021-2032)
- 8.3.2 China Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 8.3.3 Japan Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 8.3.5 India Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 8.3.7 Australia Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)

9 South America

9.1 South America Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2032)
9.2 South America Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2032)
9.3 South America Digital Therapeutics for Smoking Cessation Market Size by Country
- 9.3.1 South America Digital Therapeutics for Smoking Cessation Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Digital Therapeutics for Smoking Cessation Market Size by Country
- 10.3.1 Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
- 10.3.4 UAE Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Digital Therapeutics for Smoking Cessation Market Drivers
11.2 Digital Therapeutics for Smoking Cessation Market Restraints
11.3 Digital Therapeutics for Smoking Cessation Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Digital Therapeutics for Smoking Cessation Industry Chain
12.2 Digital Therapeutics for Smoking Cessation Upstream Analysis
12.3 Digital Therapeutics for Smoking Cessation Midstream Analysis
12.4 Digital Therapeutics for Smoking Cessation Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Digital Therapeutics for Smoking Cessation market size was valued at US$ 722 million in 2025 and is forecast to a readjusted size of US$ 2831 million by 2032 with a CAGR of 21.5% during review period.
Digital smoking cessation therapies refer to digital healthcare products that utilize software programs, mobile applications (Apps), artificial intelligence algorithms, wearable devices, sensors, virtual reality (VR), and telemedicine to provide smokers with clinically evidence-based smoking cessation intervention programs. These therapies employ cognitive behavioral therapy (CBT), motivational enhancement therapy (MET), mindfulness training, behavioral feedback, nicotine dependence management, relapse risk prediction, and personalized health guidance to help users reduce tobacco dependence, improve smoking cessation adherence, and increase long-term smoking cessation success rates. Unlike ordinary smoking cessation apps, strictly speaking digital smoking cessation therapies typically require clinical validation and are used as medical intervention tools for disease treatment or health management. They can be used independently or in combination with medication, nicotine replacement therapy (NRT), and under physician guidance.
Digital smoking cessation therapies are demonstrating immense potential to transform the global tobacco control landscape due to their superior accessibility and cost advantages. Evidence-based medicine has clearly confirmed their effectiveness: a network meta-analysis encompassing 152 trials showed that personalized and group-tailored digital interventions can increase smoking cessation rates by 86% to 93% compared to conventional care, with SMS-based interventions being particularly effective, increasing the success rate by 63%. More advanced immediate adaptive interventions and virtual reality digital therapies integrating cognitive behavioral therapy can provide precise support at users' most vulnerable moments through real-time monitoring and personalized feedback—something virtually impossible in traditional human services. Despite challenges such as varying levels of engagement and data security, with the deep integration of artificial intelligence technology and the continuous accumulation of clinical validation, these digital therapies, combining low cost, high coverage, and personalization, are expected to become a key supplement to traditional smoking cessation services, propelling tobacco control efforts into a new era of more precise and inclusive digital care.
Report Scope
This report is a detailed and comprehensive analysis for global Digital Therapeutics for Smoking Cessation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Digital Therapeutics for Smoking Cessation market size and forecasts, in consumption value ($ Million), 2021-2032
Global Digital Therapeutics for Smoking Cessation market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Digital Therapeutics for Smoking Cessation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Digital Therapeutics for Smoking Cessation market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Digital Therapeutics for Smoking Cessation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Digital Therapeutics for Smoking Cessation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Click Therapeutics, CureApp, Pelago（Quit Genius）, Ditch Labs, MindCotine, Kwit, Pivot Health, Carrot Inc., Beijing Wenzhi Technology Co., Ltd., Hangzhou Yisu Technology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Digital Therapeutics for Smoking Cessation market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Market segment by Type
Cognitive Behavioral Therapy (CBT)-based
AI-driven Personalized Intervention
Digital Behavioral Feedback
Virtual Reality (VR)-assisted
Market segment by Business Models
B2C
B2B
B2B2C
Market segment by Application
Digital Smoking Cessation Therapy for Adults
Digital Smoking Cessation Therapy for Adolescents
Digital Smoking Cessation Therapy for Special Populations
Market segment by players, this report covers
Click Therapeutics
CureApp
Pelago（Quit Genius）
Ditch Labs
MindCotine
Kwit
Pivot Health
Carrot Inc.
Beijing Wenzhi Technology Co., Ltd.
Hangzhou Yisu Technology Co., Ltd.
Shanghai Akcare Medical Technology Co., Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Digital Therapeutics for Smoking Cessation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Digital Therapeutics for Smoking Cessation, with revenue, gross margin, and global market share of Digital Therapeutics for Smoking Cessation from 2021 to 2026.
Chapter 3, the Digital Therapeutics for Smoking Cessation competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Digital Therapeutics for Smoking Cessation market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Digital Therapeutics for Smoking Cessation.
Chapter 13, to describe Digital Therapeutics for Smoking Cessation research findings and conclusion.

Buy now